Abstract:Introduction: There is a strong bidirectional relationship between nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM), both of which can lead to an increase in harmful metabolism and cardiovascular risk. It was discovered that C1q/TNF-related protein 4 (CTRP4) regulates glucolipid metabolism and feeding behavior. However, the correlation between serum CTRP4 and NAFLD in T2DM patients is not yet fully understood. Methods: This study enrolled 188 T2DM participants who were separated into 2 distinct groups (NAFLD and non-NAFLD) according to abdominal ultrasound imaging results. The enzyme-linked immunosorbent assay was utilized to evaluate the levels of serum CTRP4. Clinical data and CTRP4 concentration were compared between the two groups. Linear and logistic regression analyses were performed to evaluate the correlation of serum CTRP4 levels with NAFLD risk in T2DM patients. Results: Compared with non-NAFLD, the concentration of CTRP4 was lower in NAFLD group (median 2.46 vs. 2.89, P < 0.001). The log(CTRP4) value was found to be negatively correlated with alanine aminotransferase, aspartate aminotransferase, body mass index (BMI), and waist circumference in a Pearson correlation analyses (r = -0.159, -0.156, -0.224, -0.268, all P < 0.05); besides, the trend χ2 test demonstrated that the prevalence of NAFLD rose as CTRP4 concentration decreased (P < 0.001). Regression analysis suggested that NAFLD served as an independent factor influencing log(CTRP4) independently (β-coefficient = -0.12, P = 0.011), even after adjusting for high-sensitivity C-reactive protein and white blood cells. Finally, the results of the logistic regression analysis demonstrated that BMI [odds ratio (OR) = 1.196, P = 0.028], triglyceride (OR = 2.744, P < 0.001), and CTRP4 (OR = 0.615, P = 0.032) were independently associated with NAFLD in T2DM. Conclusions: T2DM patients with NAFLD have lower CTRP4 serum concentrations than those without NAFLD. The risk of NAFLD in patients with T2DM is inversely correlated with serum CTRP4 levels.

Plasma CTRP-3 Concentrations in Chinese Patients with Obesity and Type II Diabetes Negatively Correlate with Insulin Resistance.

Serum CTRP3 Level is Inversely Associated with Nonalcoholic Fatty Liver Disease: A 3-Y Longitudinal Study.

Circulating CTRP9 Levels Are Increased in Patients with Newly Diagnosed Type 2 Diabetes and Correlated with Insulin Resistance

Change and significance of serum CTRP3 in patients with type 2 diabetes mellitus

Plasma C1q/TNF-Related Protein-3 (CTRP-3) and High-Mobility Group Box-1 (HMGB-1) Concentrations in Subjects with Prediabetes and Type 2 Diabetes

Serum C1q/TNF-related Protein-3 (CTRP3) Levels Are Decreased in Obesity and Hypertension and Are Negatively Correlated with Parameters of Insulin Resistance

Increased plasma n-3 polyunsaturated fatty acid is associated with improved insulin sensitivity in type 2 diabetes in China.

Correlation between CTRP-3 level and obesity

Relationship Between Serum CRTC3 and Insulin Resistance in Patients with Type 2 Diabetes Mellitus and Abdominal Obesity

Decreased Serum C1Q/TNF-related Protein 4 Concentrations Are Associated with Type 2 Diabetes Mellitus

C1q/TNF-related protein-6 is associated with insulin resistance and the development of diabetes in Chinese population

Relationship between serum CTRP6 level and insulin resistance in patients with newly diagnosed type 2 diabetes mellitus

Relationship between Plasma Phospholipid Fatty Acid Profile and Insulin Resistance in Type 2 Diabetics

Serum CTRP3 Levels In Obese Children: A Potential Protective Adipokine Of Obesity, Insulin Sensitivity And Pancreatic β Cell Function.

Circulating Complement‐1q Tumor Necrosis Factor‐α‐related Protein Isoform 5 Levels Are Low in Type 2 Diabetes Patients and Reduced by Dapagliflozin

Serum C1q/TNF-Related Protein 4 Levels Are Associated with Nonalcoholic Fatty Liver Disease in Type 2 Diabetic Patients.

The circulating levels of CTRP1 and CTRP5 are associated with obesity indices and carotid intima-media thickness (cIMT) value in patients with type 2 diabetes: a preliminary study

Clinical Diagnostic Values of C1q/TNF-Related Protein-3 for Polycystic Ovary Syndrome Women with Insulin Resistance

Association between C-reactive protein and pre-diabetic status in a Chinese Han clinical population.

Serum levels of retinol binding protein 4, adiponectin and tumor necrosis factor-alpha and their correlations in patients with obesity and type 2 diabetes mellitus

Circulating C1q complement/TNF-related protein (CTRP) 1, CTRP9, CTRP12 and CTRP13 concentrations in Type 2 diabetes mellitus: In vivo regulation by glucose